J&J beats Q4 expectations, warns of sales slowdown; Behind the scenes of Lilly’s drug pricing ad decision; Cost of diabetes treatments doubled in five years.
Lawmakers want to end tax exemption for pharma ads; Gottlieb warns of “hard decisions” at FDA if shutdown continues; Feds to allow drugmakers to develop over-the-counter naloxone.
Sixteen Democratic senators are backing the latest version of a bill to end the exemption for DTC advertising.
Patients, medical groups launch campaign in opposition to Trump’s pricing proposal; Diabetes pill considered for FDA approval; The MM&M Podcast teaser.
The branding change unifies the eight regional physician groups of the Permanente Medical Group.
It’s the first step in a planned regional expansion for GCI.
Court documents detail aggressive marketing of OxyContin; Walgreens partners with Microsoft on research; Allergan wants High Court to take up Restasis patent lawsuit.
Walmart pharmacies set to leave CVS network; Edwards Lifesciences settles patent dispute with Boston Scientific; Pfizer to cut 150 R&D jobs.
With Bristol-Myers Squibb’s acquisition of Celgene set to close in Q3, the two companies have some marketing shops in common.
Hospitals required to post prices; Judge halts new rules on ACA birth control mandate; New global pharma association rules ban gifts to doctors.